AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 213 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $10,644,000 | +4716.3% | 300 | -90.9% | 0.06% | +6200.0% |
| Q1 2019 | $221,000 | -22.5% | 3,291 | -11.2% | 0.00% | 0.0% |
| Q3 2018 | $285,000 | -9.5% | 3,706 | -0.8% | 0.00% | -50.0% |
| Q2 2018 | $315,000 | +7.5% | 3,737 | +4.7% | 0.00% | 0.0% |
| Q1 2018 | $293,000 | +5.8% | 3,570 | -47.4% | 0.00% | 0.0% |
| Q1 2016 | $277,000 | -37.3% | 6,793 | -0.4% | 0.00% | -33.3% |
| Q4 2015 | $442,000 | -20.2% | 6,818 | -13.0% | 0.00% | -25.0% |
| Q3 2015 | $554,000 | -7.2% | 7,833 | +45.6% | 0.00% | 0.0% |
| Q2 2015 | $597,000 | -7.2% | 5,379 | -30.1% | 0.00% | 0.0% |
| Q1 2015 | $643,000 | -3.2% | 7,699 | +14.1% | 0.00% | 0.0% |
| Q4 2014 | $664,000 | +110.8% | 6,750 | +31.6% | 0.00% | +100.0% |
| Q3 2014 | $315,000 | – | 5,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
| Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
| Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
| HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
| Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
| Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
| Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
| Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |